Effects of benidipine in a rat model of experimental angina

Yakugaku Zasshi

Volumn 126, Issue 12, 2006, Pages 1377-1381

  Ikeda, Jun Ichi ^a   Matsubara, Masahiro ^a   Yao, Kozo ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

1,4 dihydropyridine; Angina; Benidipine

Indexed keywords

AMLODIPINE; ANTIANGINA PECTORIS AGENT; BENIDIPINE; EFONIDIPINE; NIFEDIPINE; VASOPRESSIN;

ANGINA PECTORIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CORONARY ARTERY SPASM; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; HEART MUSCLE ISCHEMIA; HYPOTENSION; MALE; NONHUMAN; RAT; TACHYCARDIA;

AMLODIPINE; ANGINA PECTORIS; ANIMALS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; MALE; NIFEDIPINE; NITROPHENOLS; ORGANOPHOSPHORUS COMPOUNDS; RATS; RATS, INBRED STRAINS;

EID: 33846163765     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.126.1377     Document Type: Article

References (21)

1. Grossman E., Messerli F. H., Prog. Cardiovasc. Dis., 47, 34-57 (2004).
2. Suzuki H., Ther. Res., 26, 1255-1268 (2005).
3. Yao K., Nagashima K., Miki H., J. Pharmacol. Sci., 100, 243-261 (2006).
4. Maturi M. F., Martin S. E., Markle D., Maxwell M., Burruss C. R., Speir E., Greene R., Ro Y. M., Vitale D., Green M. V., Goldstein S. R., Bacharach S. L., Patterson R. E., Circulation, 83, 2111-2121 (1991).
5. Karasawa A., Kubo K., Shuto K., Oka T., Nakamizo N., Arzneimittel- Forsch./Drug Res., 38, 1702-1707 (1988).
6. Hirata Y., Miyai H., Mabuchi Y., Aisaka K., J. Cardiovasc. Pharmacol., 31, 322-326 (1998).
7. Yamamoto S., Matsui K., Sasabe M., Kitano M., Ohashi N., Jpn. J. Pharmacol., 84, 196-205 (2000).
8. Mori T., Ishigai Y., Fukuzawa A., Chiba K., Shibano T., Br. J. Pharmacol., 116, 1668-1672 (1995).
9. Yao K., Shirakura S., J. Pharmacol. Sci., 95, 394-397 (2004).
10. Tanaka H., Shigenobu K., J. Pharmacol. Sci., 99, 214-220 (2005).
11. Sakata K., Shirotani M., Yoshida H., Nawada R., Obayashi K., Togi K., Miho N., Hypertension, 33, 1447-1452 (1999).
12. Nap A., Mathy M. J., Balt J. C., Pfaffendorf M., van Zwieten P. A., Fundam. Clin. Pharmacol., 18, 309-319 (2004).
13. Konda T., Enomoto A., Matsushita J., Takahara A., Moriyama T., Nephron Physiol., 101, 1-13 (2005).
14. Moriyama T., Karasawa A., Biol. Pharm. Bull., 17, 1468-1471 (1994).
15. Sato R., Jin H., Higashino R., Tanaka T., Kurimoto T., Tamaki H., Pharmacometrics, 53, 101-108 (1997).
16. Rothman M. T., Khan B., Br. J. Clin. Pract., 45, 129-134 (1991).
17. Ishii A., Nishida K., Oka T., Nakamizo N., Arzneimittel-Forsch./Drug Res., 38, 1677-1680 (1988).
18. Karasawa A., Kubo K., Jpn. J. Pharmacol., 47, 35-44 (1988).
19. Cheng C. P., Noda T., Nordlander M., Ohno M., Little W. C., J. Pharmacol. Exp. Ther., 268, 1232-1241 (1994).
20. Nayler W. G. (ed.), "Calcium Antagonists," Academic Press, London, 1998, pp. 113-129.
21. Ito A., Fukumoto Y., Shimokawa H., J. Cardiovasc. Pharmacol., 44, 480-485 (2004).